Serum insulin-like growth factor binding protein 2 is associated with hepatic steatosis in adults with metabolic dysfunction-associated steatotic liver disease

Serum insulin-like growth factor binding protein 2 is associated with hepatic steatosis in adults with metabolic dysfunction-associated steatotic liver disease

Objective: To evaluate the association between serum insulin-like growth factor binding protein 2 (IGFBP2) and the degree of hepatic steatosis in patients with MASLD. Methods: A total of 347 patients with metabolic dysfunction-associated steatotic liver disease (MASLD) were enrolled, adhering to the...

Full description

Saved in:
Bibliographic Details
Main Authors: Ziwei Wang, Hongyan Wu, Hsiuying Fu, Yingying Xue, Lixuan Shen, Jingyu Zhu, Ziwei Zhu, Xizhong Yu, Ruonan Zhou, Wenbin Shang
Format: Article
Language:English
Published: Bioscientifica 2025-07-01
Series:Endocrine Connections
Subjects:
metabolic dysfunction-associated steatotic liver disease
insulin-like growth factor binding protein 2
liver fibrosis
hepatic steatosis
Online Access:https://ec.bioscientifica.com/view/journals/ec/14/7/EC-25-0285.xml
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items